TR50 50mg*10vials

Tirzepatide TR50 50mg*10vials

Tirzepatide is a dual GLP-1 and GIP receptor agonist peptide, representing an ultra-high-concentration metabolic research compound that activates two gut hormone pathways simultaneously.

The 50mg single-vial specification delivers an exceptionally high active ingredient load per vial. This flagship formulation is designed for ultra-limited metabolic mechanism research, extreme high-dose gradient efficacy validation, large-scale long-term preclinical projects, and extreme phenotypic modeling. The high concentration per vial eliminates repeated dilution steps across extended experimental timelines, reducing data deviation and sample contamination risk.

Through combined GLP-1 and GIP receptor activation, this compound supports comprehensive research into insulin sensitivity, glycemic regulation, appetite-related signaling, and metabolic homeostasis. The dual pathway approach provides a comprehensive scope for studying systemic metabolic regulation under high-dose experimental conditions.

This product is supplied as sterile lyophilized powder in glass vials, formulated for reconstitution with bacteriostatic water. Every batch undergoes comprehensive purity testing, with a full certificate of analysis provided.

10 vials per pack, designed for top-tier professional research institutions and large-scale global procurement.